Abbott Laboratories (ABT) Announces Completion of Acquisition of Exact Sciences

This acquisition places Abbott Laboratories (NYSE:ABT) good to beforehand diagnostics, which are much preventative, predictive, and personalized. Apart from this, it added a caller maturation vertical to Abbott Laboratories (NYSE:ABT)’s already high-single-digit maturation outlook, which volition assistance found enactment successful the expanding $60 billion US marketplace focused connected crab screening and precision oncology diagnostics.

Abbott Laboratories (NYSE:ABT)’s planetary scale, past of achieving operational and commercialized excellence, and its enactment with healthcare systems should assistance successful expanding accessibility to tools for aboriginal crab detection and personalized treatments. After the completion of the acquisition, Exact Sciences is present a wholly-owned subsidiary of Abbott Laboratories (NYSE:ABT).

Abbott Laboratories (NYSE:ABT) is simply a planetary healthcare institution that manufactures a scope of branded generic medications, aesculapian devices, diagnostics, and nutritional items.

While we admit the imaginable of ABT arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 10 Best FMCG Stocks to Invest In According to Analysts and 11 Best Long-Term Tech Stocks to Buy According to Analysts.

Disclosure: None. Follow Insider Monkey connected Google News.